PCN Insights, News, Videos, and More

The COVID-19 pandemic has resulted in dramatic changes to sleep patterns at a time when the health benefits from quality sleep are especially important, researcher and sleep expert Charles M. Morin, PhD, said at a virtual symposium.

Setting clear and attainable goals, praising genuine efforts, and allowing failure are key in supporting children’s virtual learning efforts during the pandemic, according to a session presented at the Anxiety and Depression Association of...

Confirming results from a previous smaller study, researchers found people who reported a history of childhood maltreatment had a more robust response to intravenous (IV) ketamine than other depressed adults seeking ketamine treatment.

More than half of 3904 US adults with previous COVID-19 illness met criteria for moderate or greater symptoms of major depressive disorder months later, according to a study published online in a research letter in JAMA Network Open.

Adults aged 65 years or older who had clinically significant fatigue at baseline had greater improvements in the Fatigue Severity Scale total score and all sleep parameters 6 months later, compared with placebo, a post hoc analysis of a phase...

Rather than compromise mental health, quitting smoking for at least 6 weeks can reduce anxiety, depression, and stress and improve mental well-being, according to an evidence review published in the Cochrane Database of Systematic...

The prevalence of dementia in the United States is projected to triple in approximately the next 20 years, but there are several modifiable risk factors that could reduce the likelihood of developing the disease, Kristine Yaffe, MD, said in a...

Sage Therapeutics has released complete data from a 12-month study of patients taking 30 mg of the investigational oral neuroactive steroid zuranolone for major depressive disorder (MDD) and interim data on a cohort receiving a 50 mg dose.